查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786785

儿童糖尿病治疗的全球市场，规模，占有率，趋势，产业分析报告:各类型，不同治疗，各给药途径，各用途，各流通管道，各地区 - 市场预测，2025年～2034年

Pediatric Diabetes Therapeutic Market Size, Share, Trends, & Industry Analysis Report By Type (Type 1, Type 2), By Therapy, By Route of Administration, By Application, By Distribution Channel, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，儿童糖尿病治疗市场规模将达到 346 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

儿童糖尿病治疗包括胰岛素治疗、口服降血糖药、GLP-1 受体激动剂以及专为第 1 型和第 2 型糖尿病儿童和青少年设计的数位血糖监测技术。由于数位疗法、整合胰岛素输送系统和即时血糖监测平台的日益普及，市场正在经历重大转型。

市场成长的关键驱动力是儿童 1 型糖尿病盛行率的上升、早发性 2 型糖尿病诊断的增加，以及远端监控和数位治疗平台的日益融合。儿科专用胰岛素给药系统开发的进展以及非胰岛素疗法监管审批的不断扩大，正在促进已开发地区和新兴地区的治疗便利性和市场扩张。

儿童糖尿病治疗市场报告重点

按类型划分，由于第1型糖尿病在儿科人群中的患病率高且需要终身胰岛素治疗，预计2024年1型糖尿病将占据最大占有率。

依治疗方式划分，胰岛素治疗领域在2024年占据市场主导地位。这是由于其在儿科糖尿病治疗中的重要作用以及智慧和数位化整合给药系统的日益普及。

依给药途径划分，由于胰岛素注射和智慧给药系统在临床和家庭环境中的广泛应用，肠外给药领域在2024年占据最大市场占有率。

依应用划分，胰岛素製剂是儿童第1型糖尿病和晚期第2型糖尿病的主要治疗方法， 2024年占据市场主导地位。

在通路方面，医院细分市场在2024年占据市场主导地位，这得益于高诊断量和获得先进治疗的便利性。

2024年，北美占据全球儿科糖尿病治疗市场的大部分占有率，这得益于早期采用结构化儿科内分泌护理和数位化糖尿病管理技术。

由于儿科糖尿病患者数量的增加和政府医疗保健投资的增加，预计亚太地区将在预测期内经历显着增长。

全球主要市场参与者包括 Novo Nordisk A/S、赛诺菲、礼来公司、美敦力公司、雅培实验室、F. Hoffmann-La Roche Ltd、Dexcom Inc.、Insulet Corporation、Tandem Diabetes Care Inc.、Ascensia Diabetes Care Holdings AG、Glenmark Pharmaceuticals Ltd. 和 Biocontes Care Holdings AG、Glenmark Pharmaceuticals Ltd. 和 Biocontes Care Holdings AG、Glenmark Pharmaceuticals Ltd. 和 Biocontes Care Holdings AG、Glenmark Pharmaceuticals Ltd. 和 Biocontes Care Holdings AG、Glenmark Pharmaceuticals Ltd. 和 Biocontes Care Holdings。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球儿童糖尿病治疗市场洞察

  • 市场概述
  • 儿童糖尿病治疗市场动态
    • 促进因素和机会
      • 全球儿童第一型糖尿病发生率不断上升
      • 远端监控和数位疗法的普及率不断提高
    • 阻碍因素与课题
      • 高成本与取得途径有限
  • PESTEL分析
  • 儿童糖尿病治疗市场趋势
  • 价值链分析

第5章 全球儿童糖尿病治疗市场:各类型

  • 主要调查结果
  • 简介
  • 第一型
  • 2型

第6章 全球儿童糖尿病治疗市场:不同治疗

  • 主要调查结果
  • 简介
  • 药物疗法
  • 胰岛素疗法

第7章 全球儿童糖尿病治疗市场:各给药途径

  • 主要调查结果
  • 简介
  • 口服给药
  • 鼻腔给药
  • 非口服给药

第8章 全球儿童糖尿病治疗市场:各用途

  • 主要调查结果
  • 简介
  • 胰岛素
  • GLP-1受体激动剂
  • 双胍类(Biguanides)
  • SGLT2抑制剂
  • 其他

第9章 全球儿童糖尿病治疗市场:各流通管道

  • 主要调查结果
  • 简介
  • 医院
  • 专门诊所
  • 零售药局
  • 药妆店

第10章 全球儿童糖尿病治疗市场:各地区

  • 主要调查结果
  • 简介
    • 儿童糖尿病治疗市场评估:各地区，2020年～2034年
  • 北美
    • 北美:各类型，2020～2034年
    • 北美:不同治疗，2020～2034年
    • 北美:各给药途径，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各流通管道，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型，2020～2034年
    • 欧洲:不同治疗，2020～2034年
    • 欧洲:各给药途径，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各流通管道，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型，2020～2034年
    • 亚太地区:不同治疗，2020～2034年
    • 亚太地区:各给药途径，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:各流通管道，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型，2020～2034年
    • 中东·非洲:不同治疗，2020～2034年
    • 中东·非洲:各给药途径，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各流通管道，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类型，2020-2034年
    • 南美:不同治疗，2020～2034年
    • 南美:各给药途径，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各流通管道，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Biocon Limited
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Glenmark Pharmaceuticals Ltd.
  • Insulet Corporation
  • Medtronic plc
  • Novo Nordisk A/S
  • Sanofi
  • Tandem Diabetes Care Inc.
Product Code: PM6054

The pediatric diabetes therapeutics market size is expected to reach USD 34.60 Billion by 2034, according to a new study by Polaris Market Research. The report "Pediatric Diabetes Therapeutic Market Size, Share, Trends, & Industry Analysis Report By Type (Type 1, Type 2), By Therapy, By Route of Administration, By Application, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pediatric diabetes therapeutics include insulin therapies, oral antidiabetic drugs, GLP-1 receptor agonists and digital glucose monitoring technologies designed for children and adolescents diagnosed with type 1 and type 2 diabetes. The market is witnessing significant transformation through increased adoption of digital therapeutics, integrated insulin delivery systems, and real-time glucose monitoring platforms.

Market growth is primarily driven by the rising incidence of type 1 diabetes among children, growing diagnosis of early-onset type 2 diabetes and increasing integration of remote monitoring and digital therapeutic platforms. Growing advancements in pediatric-specific insulin delivery systems and expanding regulatory approvals for non-insulin therapies are contributing to treatment accessibility and market expansion across developed and emerging regions.

Pediatric Diabetes Therapeutic Market Report Highlights

Based on type, the type 1 segment accounted for largest share in 2024, due to high prevalence and the requirement for lifelong insulin therapy in pediatric populations.

In terms of therapy, the insulin therapy segment dominated the market in 2024. This is driven by its key role in pediatric diabetes care and growing adoption of smart & digitally integrated delivery systems.

Based on route of administration, the parenteral administration segment held the largest market share in 2024 due to its widespread adoption of insulin injections and smart delivery systems in clinical and home settings.

Based on application, the insulin segment dominated the market in 2024, as it remains the primary treatment for pediatric type 1 diabetes and advanced type 2 cases.

In terms of distribution channel, the hospitals segment dominated the market in 2024. This is fueled by high diagnosis volume and access to advanced therapies.

North America accounted for the majority share in the global pediatric diabetes therapeutic market in 2024, fueled by fueled by structured pediatric endocrinology care and early adoption of digital diabetes management technologies.

Asia Pacific is expected to grow significantly during the forecast period, fueled by increasing childhood diabetes cases and government healthcare investments.

A few global key market players include Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glenmark Pharmaceuticals Ltd., and Biocon Limited.

Polaris Market Research has segmented the market report on the basis of type, therapy, route of administration, application, distribution channel, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Type 1

Type 2

By Therapy Outlook (Revenue, USD Billion, 2020-2034)

Drug Therapy

Biguanide

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

Insulin Therapy

Rapid-acting Insulin

Short-acting Insulin

Intermediate-acting Insulin

Long-acting Insulin

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral Administration

Nasal Administration

Parenteral Administration

Subcutaneous

Intramuscular

Intravenous

By Application Outlook (Revenue, USD Billion, 2020-2034)

Insulin

GLP-1 Receptor Agonists

Biguanide

SGLT2 Inhibitors

Other Application

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Specialty Clinics

Retail Pharmacies

Drug Stores

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pediatric Diabetes Therapeutic Market Insights

  • 4.1. Pediatric Diabetes Therapeutic Market - Market Snapshot
  • 4.2. Pediatric Diabetes Therapeutic Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence of Type 1 Diabetes in Children Globally
      • 4.2.1.2. Growing Adoption of Remote Monitoring and Digital Therapeutics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs and Limited Access
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Pediatric Diabetes Therapeutic Market Trends
  • 4.6. Value Chain Analysis

5. Global Pediatric Diabetes Therapeutic Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Type 1
    • 5.3.1. Global Pediatric Diabetes Therapeutic Market, by Type 1, by Region, 2020-2034 (USD Billion)
  • 5.4. Type 2
    • 5.4.1. Global Pediatric Diabetes Therapeutic Market, by Type 2, by Region, 2020-2034 (USD Billion)

6. Global Pediatric Diabetes Therapeutic Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • 6.3. Drug Therapy
    • 6.3.1. Global Pediatric Diabetes Therapeutic Market, by Drug Therapy, by Region, 2020-2034 (USD Billion)
  • 6.4. Insulin Therapy
    • 6.4.1. Global Pediatric Diabetes Therapeutic Market, by Insulin Therapy, by Region, 2020-2034 (USD Billion)

7. Global Pediatric Diabetes Therapeutic Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Oral Administration
    • 7.3.1. Global Pediatric Diabetes Therapeutic Market, by Oral Administration, by Region, 2020-2034 (USD Billion)
  • 7.4. Nasal Administration
    • 7.4.1. Global Pediatric Diabetes Therapeutic Market, by Nasal Administration, by Region, 2020-2034 (USD Billion)
  • 7.5. Parenteral Administration
    • 7.5.1. Global Pediatric Diabetes Therapeutic Market, by Parenteral Administration, by Region, 2020-2034 (USD Billion)

8. Global Pediatric Diabetes Therapeutic Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Insulin
    • 8.3.1. Global Pediatric Diabetes Therapeutic Market, by Insulin, by Region, 2020-2034 (USD Billion)
  • 8.4. GLP-1 Receptor Agonists
    • 8.4.1. Global Pediatric Diabetes Therapeutic Market, by GLP-1 Receptor Agonists, by Region, 2020-2034 (USD Billion)
  • 8.5. Biguanide
    • 8.5.1. Global Pediatric Diabetes Therapeutic Market, by Biguanide, by Region, 2020-2034 (USD Billion)
  • 8.6. SGLT2 Inhibitors
    • 8.6.1. Global Pediatric Diabetes Therapeutic Market, by SGLT2 Inhibitors, by Region, 2020-2034 (USD Billion)
  • 8.7. Other Application
    • 8.7.1. Global Pediatric Diabetes Therapeutic Market, by Other Application, by Region, 2020-2034 (USD Billion)

9. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Pediatric Diabetes Therapeutic Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 9.4. Specialty Clinics
    • 9.4.1. Global Pediatric Diabetes Therapeutic Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
  • 9.5. Retail Pharmacies
    • 9.5.1. Global Pediatric Diabetes Therapeutic Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 9.6. Drug Stores
    • 9.6.1. Global Pediatric Diabetes Therapeutic Market, by Drug Stores, by Region, 2020-2034 (USD Billion)

10. Global Pediatric Diabetes Therapeutic Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Pediatric Diabetes Therapeutic Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Pediatric Diabetes Therapeutic Market - North America
    • 10.3.1. North America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.3.3. North America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.4. North America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.3.5. North America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.3.6. Pediatric Diabetes Therapeutic Market - U.S.
      • 10.3.6.1. U.S.: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.3.7. Pediatric Diabetes Therapeutic Market - Canada
      • 10.3.7.1. Canada: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4. Pediatric Diabetes Therapeutic Market - Europe
    • 10.4.1. Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.6. Pediatric Diabetes Therapeutic Market - UK
      • 10.4.6.1. UK: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.7. Pediatric Diabetes Therapeutic Market - France
      • 10.4.7.1. France: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.8. Pediatric Diabetes Therapeutic Market - Germany
      • 10.4.8.1. Germany: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.9. Pediatric Diabetes Therapeutic Market - Italy
      • 10.4.9.1. Italy: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.10. Pediatric Diabetes Therapeutic Market - Spain
      • 10.4.10.1. Spain: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.11. Pediatric Diabetes Therapeutic Market - Netherlands
      • 10.4.11.1. Netherlands: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.12. Pediatric Diabetes Therapeutic Market - Russia
      • 10.4.12.1. Russia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.13. Pediatric Diabetes Therapeutic Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5. Pediatric Diabetes Therapeutic Market - Asia Pacific
    • 10.5.1. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.6. Pediatric Diabetes Therapeutic Market - China
      • 10.5.6.1. China: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.7. Pediatric Diabetes Therapeutic Market - India
      • 10.5.7.1. India: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.8. Pediatric Diabetes Therapeutic Market - Malaysia
      • 10.5.8.1. Malaysia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.9. Pediatric Diabetes Therapeutic Market - Japan
      • 10.5.9.1. Japan: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.10. Pediatric Diabetes Therapeutic Market - Indonesia
      • 10.5.10.1. Indonesia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.11. Pediatric Diabetes Therapeutic Market - South Korea
      • 10.5.11.1. South Korea: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.12. Pediatric Diabetes Therapeutic Market - Australia
      • 10.5.12.1. Australia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.13. Pediatric Diabetes Therapeutic Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.6. Pediatric Diabetes Therapeutic Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.6. Pediatric Diabetes Therapeutic Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.7. Pediatric Diabetes Therapeutic Market - UAE
      • 10.6.7.1. UAE: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.8. Pediatric Diabetes Therapeutic Market - Israel
      • 10.6.8.1. Israel: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.9. Pediatric Diabetes Therapeutic Market - South Africa
      • 10.6.9.1. South Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.10. Pediatric Diabetes Therapeutic Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.7. Pediatric Diabetes Therapeutic Market - Latin America
    • 10.7.1. Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.6. Pediatric Diabetes Therapeutic Market - Mexico
      • 10.7.6.1. Mexico: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.7. Pediatric Diabetes Therapeutic Market - Brazil
      • 10.7.7.1. Brazil: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.8. Pediatric Diabetes Therapeutic Market - Argentina
      • 10.7.8.1. Argentina: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.9. Pediatric Diabetes Therapeutic Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Ascensia Diabetes Care Holdings AG
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Biocon Limited
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Dexcom Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Eli Lilly and Company
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. F. Hoffmann-La Roche Ltd
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Glenmark Pharmaceuticals Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Insulet Corporation
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Medtronic plc
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Novo Nordisk A/S
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Sanofi
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Tandem Diabetes Care Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development

List of Tables:

  • Table 1 Global Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 3 Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 5 Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 6 North America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 7 North America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 8 North America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 North America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 10 North America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 11 U.S.: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 13 U.S.: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 U.S.: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 15 U.S.: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 Canada: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 18 Canada: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 19 Canada: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Canada: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 23 Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 26 UK: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 27 UK: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 28 UK: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 UK: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 30 UK: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 France: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 32 France: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 33 France: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 France: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 35 France: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 36 Germany: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 38 Germany: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 39 Germany: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Germany: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 41 Italy: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 43 Italy: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Italy: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Italy: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 Spain: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 48 Spain: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Spain: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 50 Spain: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 56 Russia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 58 Russia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 59 Russia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Russia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 71 China: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 72 China: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 73 China: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 China: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 75 China: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 India: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 77 India: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 78 India: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 79 India: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 80 India: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 86 Japan: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 88 Japan: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Japan: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Japan: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 96 South Korea: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 98 South Korea: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 99 South Korea: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 100 South Korea: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 101 Australia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 103 Australia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Australia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 105 Australia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 121 UAE: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 123 UAE: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 UAE: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 125 UAE: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 126 Israel: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 128 Israel: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Israel: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 130 Israel: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 131 South Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 133 South Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 134 South Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 135 South Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 141 Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 143 Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 144 Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 145 Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 146 Mexico: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 148 Mexico: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 149 Mexico: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 150 Mexico: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 151 Brazil: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 153 Brazil: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 154 Brazil: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 155 Brazil: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 156 Argentina: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 158 Argentina: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 159 Argentina: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 160 Argentina: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Pediatric Diabetes Therapeutic Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Pediatric Diabetes Therapeutic Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Pediatric Diabetes Therapeutic Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Pediatric Diabetes Therapeutic Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Distribution Channel
  • Figure 15. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2024 & 2034 (USD Billion)